- Home
- CELU vs AIFA Comparison
CELU vs AIFA Comparison
Compare CELU & AIFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.42
N/A
Current Price
$4.08
Company Overview
Basic Information| Metric | CELU | AIFA |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 14.7M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CELU | AIFA |
|---|---|---|
| Price | $1.42 | $4.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 417.2K | 54.1K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,550,000.00 | $7,655,039.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.50 |
| 52 Week Low | $0.56 | $1.52 |
| 52 Week High | $2.55 | $4.40 |
Technical Indicators
Market Signals| Indicator | CELU | AIFA |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 71.59 |
| Support Level | $1.10 | $2.80 |
| Resistance Level | $1.43 | N/A |
| Average True Range (ATR) | 0.12 | 0.28 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 61.90 | 71.95 |
Price Performance
Historical Comparison CELU
AIFA
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.